A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab
Clinical Trial ID NCT00875979
PubWeight™ 4.06‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00875979
Top papers
Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
Next 100